Sex Hormones and Cardiovascular Diseases: From Pathophysiology to Novel Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 144
Special Issue Editors
Interests: reactive oxygen species; antioxidants; physical exercise; metabolic disorders
Special Issues, Collections and Topics in MDPI journals
Interests: cardiovascular diseases; physical exercise; antioxidants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The purpose of this Special Issue is to examine sexual dimorphism in relation to cardiovascular diseases (CVDs) and to explore the complex interplay between sex hormone disorders and CVDs. Understanding sex hormone disorders associated with cardiovascular disease may improve our insights into cardiovascular disease’s pathogenesis, with potential to translate this into improved individualized care for men and women with or at risk of cardiovascular disease.
In this Special Issue, we welcome the submission of reviews, original research, short communications, as well as perspectives that cover but are not limited to the following topics:
- Sexual dimorphism and CVDs.
- Aging, sex hormones, and CVDs.
- How sex steroids are beneficial or detrimental in CVDs.
- Molecular mechanisms, unfavorable hormone profiles, and their interplay with CVDs.
- Emerging drugs and biological agents aimed at hormonal imbalances.
- Animal models for understanding the interplay between hormonal disturbances and CVDs.
Dr. Renáta Szabó
Dr. Denise Börzsei
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endogenous sex hormones
- aging
- sexual dimorphism
- hormone replacement therapy
- CVDs
- hypertension
- myocardial infarction
- atherosclerosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
